Status: Not yet recruiting
Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine
This is a randomized, double-blinded, parallel-controlled phase I/II clinical trial to evaluate the safety and preliminary immunogenicity of the Tetanus, Diphtheria and Acellular Component Pertussis Vaccine Adsorbed (reduced antigen content) in subjects aged 6 years and above.
Participants needed: 660
Trial details
Phase: Phase 1, Phase 2Age: 6+Biological sex: AllType: InterventionalSponsor: Institute of Medical Biology, Chinese Academy of Medical SciencesUpdated: Feb 18, 2026Locations: 1
Eligibility criteria
Age Requirement: volunteers aged 6 years and above [+2]
Subjects whose physical examination, vital signs check, or laboratory test resul... [+14]